A Randomized Double-Blind Comparative Study of YLB217 and Recombinant Darbepoetin alfa in Renal Anemia Patients on Hemodialysis
A Randomized Double-Blind Comparative Study of YLB217 and Recombinant Darbepoetin alfa in Renal Anemia Patients on Hemodialysis
A Comparative Study to Assess the Efficacy, Safety and Immunogenicityof YLB113 and Enbrel for the Treatment of Rheumatoid Arthritis
100 Clinical Results associated with YL Biologics Ltd.
0 Patents (Medical) associated with YL Biologics Ltd.
100 Deals associated with YL Biologics Ltd.
100 Translational Medicine associated with YL Biologics Ltd.